글로벌 불면증 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 불면증 시장

불면증 시장은 2022-2029년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 5.4%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다. 이 시장의 성장을 주도하는 요인은 신흥 시장과 연구 개발에 대한 막대한 투자입니다.

불면증은 사람이 잠들거나 잠을 유지하기 어려운 수면 장애입니다. 저체온증, 주간 졸음증, 우울증 및 과민성이 증상 중 일부입니다. 전 세계 수백만 명의 사람들에게 영향을 미치는 매우 흔한 장애입니다. 일주기 리듬 장애, 만성 통증, 갑상선 기능 항진증 , 폐경, 심리적 스트레스 및 기타 의학적 상태가 모두 불면증에 기여합니다. 또한 카페인, 알코올 및 니코틴과 같은 약물을 과도하게 사용하면 불면증이 발생할 수 있습니다. 수면 실험실에서는 이 장애를 진단하기 위해 다양한 진단 장치를 사용합니다.

스트레스 수치 상승, 시장에 특허 분자 존재, 임상 파이프라인의 잠재적 약물, 기술적으로 진보된 의료 기기 도입, 노령 인구 증가는 모두 불면증 치료제 시장 성장에 영향을 미치는 요인입니다. 수면 부족이 일상 생활에 미치는 영향에 대한 인식이 높아지면서 다양한 불면증 치료법의 채택률이 증가하여 불면증 치료제 시장의 수익이 증가할 것으로 예상됩니다.

Other factors, such as side effects from certain over-the-counter and prescription medications, arthritis, and excessive use of media devices before bed, are increasing the number of people suffering from insomnia, boosting market growth prospects. Furthermore, the rise in psychological disorders and the ever-increasing noise levels in cities will drive the insomnia treatment market during the forecast period. Furthermore, emerging markets and significant investment in research and development are driving this market's growth.

However, misconceptions about the seriousness of insomnia, as well as patient non-adherence to treatment, are among the factors expected to limit market growth over the forecast period. Dearth of skilled medical professionals and lack of a strong healthcare infrastructure in the backward economies are further derailing the market growth rate

This insomnia market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the insomnia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Insomnia Market Scope and Market Size

The insomnia market is segmented on the basis of therapy type, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of therapy type, the global insomnia market is segmented into non-pharmacological and pharmacological therapy
• Based on drug class, the global insomnia market is segmented into melatonin antagonist, antidepressants, benzodiazepines, non-benzodiazepines and others.
• Route of administration segment for global insomnia market is categorized into oral, parenteral and others.
• On the basis of end-users, the global insomnia market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the global insomnia market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.

Insomnia Market Country Level Analysis

Insomnia market is analysed and market size information is provided by the country, therapy type, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the insomnia market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the global insomnia market and will flourish its dominance over the forecast period because of global leaders in research and development activities, an established approval process framework, an increase in the number of FDA-approved drugs and rise in the patient suffering from mental illness. Asia-Pacific is projected to score the highest growth rate owing to the developing healthcare facilities, a large number of generic manufacturers, and an increase in government initiatives and specialist communities.

The country section of the insomnia market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Insomnia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to insomnia market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the insomnia market in the growth period.

Competitive Landscape and Insomnia Market Share Analysis

불면증 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 제공된 위의 데이터 포인트는 글로벌 불면증 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

불면증 시장의 주요 기업으로는 Takeda Pharmaceutical Company Limited., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Endo International plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan NV, Novartis AG, Lupin., Cipla Inc., Aurobindo Pharma., Torrent Pharmaceuticals Ltd, Alvogen., Merck Sharp & Dohme Corp., Apotex Inc., Zydus Cadila., Saneca Pharmaceuticals, Unichem Laboratories, Neuland Laboratories Ltd., Divi's Laboratories Limited, HIKAL Ltd. 등이 있습니다.

SKU-26988